NeuroFrontiers podcast

Evolutions in Duchenne Muscular Dystrophy: Treatment Implications for the Present and Future

0:00
NaN:NaN:NaN
15 Sekunden vorwärts
15 Sekunden vorwärts
Host: Craig M. McDonald, MD
Guest: Crystal Proud, MD
Guest: Aravindhan Veerapandiyan, MD

There are ongoing clinical trials and approvals for new genetic and non-genetic therapies for Duchenne muscular dystrophy. Determining the most suitable therapy for each patient is a developing process. This education covers dystrophin disruption and restoration, recent clinical trial outcomes from different treatment methods, and a case study exploring novel patient management strategies.

Weitere Episoden von „NeuroFrontiers“